Loading
A phase 2/3 trial in colorectal cancer, run by Ain Shams University, now recruiting.
Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis is a phase 2/3, randomised interventional study registered as NCT07736495 by Ain Shams University, with a registry enrolment figure of 50 participants, started 2026-07-27 and due to reach its primary completion in 2026-12-27. Interventions recorded: alpha lipoic acid 600 mg twice daily; Placebo Tablet. Conditions listed: Colorectal Cancer. Primary outcome: Serum levels of malondialdehyde (MDA). Sites: Egypt. No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.